Gsa Capital Partners LLP Evelo Biosciences, Inc. Transaction History

Gsa Capital Partners LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$1.46 - $3.55 $106,391 - $258,692	-72,871 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$2.66 - $6.63 $193,836 - $483,134	72,871 New	72,871 $247,000
Q4 2021 Feb 14, 2022	SELL	$6.07 - $12.0 $70,557 - $139,488	-11,624 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.79 - $13.9 $78,926 - $161,573	11,624 New	11,624 $82,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.